Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

flolan 1.5mg powder and solvent (ph12) for solution for infusion vials

ph12) for solution for infusion vials (glaxosmithkline uk ltd - epoprostenol sodium - powder and solvent for solution for infusion - 1.5mg

Flolan 500microgram powder and solvent (pH12) for solution for infusion vials Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

flolan 500microgram powder and solvent (ph12) for solution for infusion vials

ph12) for solution for infusion vials (glaxosmithkline uk ltd - epoprostenol sodium - powder and solvent for solution for infusion - 500microgram

DEXMEDETOMIDINE SANDOZ dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dexmedetomidine sandoz dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection vial

sandoz pty ltd - dexmedetomidine hydrochloride, quantity: 118 microgram/ml - injection, intravenous infusion - excipient ingredients: water for injections; sodium chloride - icu sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine sandoz by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.